MDS medical refers to Myelodysplastic Syndromes (MDS), a group of rare blood cancers where the body doesn't produce enough healthy blood cells.
Understanding Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes are a diverse group of bone marrow failure disorders. Here's a breakdown:
-
Definition: MDS is a type of cancer that affects the bone marrow's ability to produce healthy blood cells. This leads to a deficiency in one or more types of blood cells, such as red blood cells, white blood cells, or platelets.
-
Rarity: MDS is considered a rare form of blood cancer.
-
Variable Severity: The severity of MDS can vary significantly.
- Some types are mild and progress slowly over many years.
- Other types are more aggressive and can transform into acute myeloid leukemia (AML).
-
Impact on Blood Cells: Because the bone marrow isn't functioning correctly, individuals with MDS may experience:
- Anemia: Low red blood cell count, leading to fatigue and weakness.
- Leukopenia: Low white blood cell count, increasing the risk of infections.
- Thrombocytopenia: Low platelet count, leading to easy bleeding and bruising.
